BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16882750)

  • 1. Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome.
    Murphy MK; Hall JE; Adams JM; Lee H; Welt CK
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3878-84. PubMed ID: 16882750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM; Taylor AE; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.
    Alsamarai S; Adams JM; Murphy MK; Post MD; Hayden DL; Hall JE; Welt CK
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4961-70. PubMed ID: 19846740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.
    Welt CK; Gudmundsson JA; Arason G; Adams J; Palsdottir H; Gudlaugsdottir G; Ingadottir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4842-8. PubMed ID: 17003085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus.
    Codner E; Soto N; Lopez P; Trejo L; Avila A; Eyzaguirre FC; Iniguez G; Cassorla F
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2250-6. PubMed ID: 16569737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
    Dewailly D; Lujan ME; Carmina E; Cedars MI; Laven J; Norman RJ; Escobar-Morreale HF
    Hum Reprod Update; 2014; 20(3):334-52. PubMed ID: 24345633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome.
    Wang JG; Lobo RA
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1394-7. PubMed ID: 18230664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
    Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
    Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
    Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
    Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
    Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
    Sahmay S; Atakul N; Oncul M; Tuten A; Aydogan B; Seyisoglu H
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):157-61. PubMed ID: 23806449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone.
    Villarroel C; Merino PM; López P; Eyzaguirre FC; Van Velzen A; Iñiguez G; Codner E
    Hum Reprod; 2011 Oct; 26(10):2861-8. PubMed ID: 21784736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hyperandrogenemia in the presence and absence of a western-style diet impairs ovarian and uterine structure/function in young adult rhesus monkeys.
    Bishop CV; Mishler EC; Takahashi DL; Reiter TE; Bond KR; True CA; Slayden OD; Stouffer RL
    Hum Reprod; 2018 Jan; 33(1):128-139. PubMed ID: 29190387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?
    Lauritsen MP; Pinborg A; Loft A; Petersen JH; Mikkelsen AL; Bjerge MR; Nyboe Andersen A
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):584-91. PubMed ID: 25262871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB; Vanky E; Carlsen SM
    Hum Reprod; 2012 Aug; 27(8):2494-502. PubMed ID: 22693172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.